These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 5523876)

  • 21. [Study of the hypouricemic effect of benziodarone in chronic renal insufficiency].
    Ponticelli C; Locatelli F; Graziani G
    Arch Ital Urol Nefrol; 1967; 40(6):461-75. PubMed ID: 5607121
    [No Abstract]   [Full Text] [Related]  

  • 22. Uricosuric effect of benziodarone in man and laboratory animals: a comparative study.
    Lemieux G; Gougoux A; Vinay P; Michaud G
    Am J Physiol; 1973 Jun; 224(6):1431-9. PubMed ID: 4197184
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of drugs on the renal handling of urate.
    Emmerson BT
    Prog Biochem Pharmacol; 1974; 9():142-52. PubMed ID: 4438376
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical and biochemical study of a new uricosuric: benziodarone].
    Rapado A; Llamazares C
    Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):249-51. PubMed ID: 5736091
    [No Abstract]   [Full Text] [Related]  

  • 25. Uricosuric potency of 2-substituted analogs of probenecid.
    Blanchard KC; Maroske D; May DG; Weiner IM
    J Pharmacol Exp Ther; 1972 Feb; 180(2):397-410. PubMed ID: 4622053
    [No Abstract]   [Full Text] [Related]  

  • 26. Studies with some novel uricosuric agents and their metabolites: correlation between clinical activity and drug-induced displacement of urate from its albumin-binding sites.
    Schlosstein LH; Kippen I; Whitehouse MW; Bluestone R; Paulus HE; Klinenberg JR
    J Lab Clin Med; 1973 Sep; 82(3):412-8. PubMed ID: 4740876
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effect of transtubular transport inhibitors in the renal excretion of uric acid in the rat].
    Boudry JF
    Pflugers Arch; 1971; 328(4):279-91. PubMed ID: 5107270
    [No Abstract]   [Full Text] [Related]  

  • 28. [Comparative study of the hypouricemic effects of calcitonin and sulfinpyrazone].
    Rico Lenza H; Huertas García-Alejo R; del Río Vázquez A; Espinós Pérez D
    Rev Clin Esp; 1982 Feb; 164(4):249-52. PubMed ID: 6283606
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical and biological action of a new hypouricemiant (benziodarone) in gout. Results of 2 years of experience].
    Santamaría A; Barceló P
    Rev Esp Reum Enferm Osteoartic; 1968 Oct; 12(8):252-63. PubMed ID: 4899417
    [No Abstract]   [Full Text] [Related]  

  • 30. [Anuria due to bilateral ureteral uric acid lithiasis during a treatment with Amplivix].
    Navas P; Grasset D
    J Urol Nephrol (Paris); 1973 Dec; 79(12 Pt 2):466-9. PubMed ID: 4804419
    [No Abstract]   [Full Text] [Related]  

  • 31. Uric acid in advanced renal failure.
    Danovitch GM; Weinberger J; Berlyne GM
    Clin Sci; 1972 Sep; 43(3):331-41. PubMed ID: 5077512
    [No Abstract]   [Full Text] [Related]  

  • 32. [On clinical experiences with 2-ethyl-3(4-hydroxy-3,5-dibrombenzoyl)-benzofuran ("Benzbromaron") in the therapy of gout and hyperuricemia].
    Kotzaurek R; Hueber EF
    Wien Med Wochenschr; 1968 Nov; 118(47):1014-8. PubMed ID: 5704263
    [No Abstract]   [Full Text] [Related]  

  • 33. Pharmacology of pyrazinamide: metabolic and renal function studies related to the mechanism of drug-induced urate retention.
    Weiner IM; Tinker JP
    J Pharmacol Exp Ther; 1972 Feb; 180(2):411-34. PubMed ID: 4622054
    [No Abstract]   [Full Text] [Related]  

  • 34. [Benziodarone and extrarenal excretion of uric acid].
    Bianco G; Bravi A; Carcassi A; Lunghetti R; Di Paolo N
    Reumatismo; 1969; 21(5):261-4. PubMed ID: 5404974
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of gout and hyperuricemia.
    Wisner DE; Simkin PA
    Prim Care; 1984 Jun; 11(2):283-94. PubMed ID: 6206519
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Studies of the mechanisms of extrarenal excretion of uric acid during treatment with benziodarone].
    Bianco G; Carcassi A; Di Paolo N; Bravi A; Lunghetti R; Zolfanelli R
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):870-82. PubMed ID: 5760333
    [No Abstract]   [Full Text] [Related]  

  • 37. [Renal physiopathology of uric acid. Pharmacologic study].
    Muñoz Sanz A; García Puig J; Mateos F; Barbado FJ
    Med Clin (Barc); 1982 Jan; 78(2):70-4. PubMed ID: 7070134
    [No Abstract]   [Full Text] [Related]  

  • 38. [Diagnosis and therapy of gout and hyperuricemia].
    Guzmán L
    Rev Med Chil; 1981 Dec; 109(12):1191-7. PubMed ID: 7346920
    [No Abstract]   [Full Text] [Related]  

  • 39. Studies on the mechanism of ethambutol-induced hyperuricemia.
    Postlethwaite AE; Kelley WN
    Arthritis Rheum; 1972; 15(4):403-9. PubMed ID: 5046470
    [No Abstract]   [Full Text] [Related]  

  • 40. [Study of the effects of benziodarone in 100 gouty patients during a diuresis cure: effects on uric acid and oxalic acid].
    Mugler A
    Rein Foie; 1967; 10():273-92. PubMed ID: 6081455
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.